CVS Health Corporation (NYSE: CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here's what you need to know.
J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVSHealth (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill ...
Some results have been hidden because they may be inaccessible to you